1-5 of 5
QIUHE JI
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Meeting Abstracts

203-LB: Prevalence and Risk Factors of Diabetic Peripheral Neuropathy—A Population-Based Cross-Sectional Study in China

WEIMIN WANG, QIUHE JI, XINGWU RAN, CHENXI LI, YAOMING XUE, BO FENG, DALONG ZHU
Journal: Diabetes
Diabetes 2023;72(Supplement_1):203-LB
https://doi.org/10.2337/db23-203-LB
Published: 20 June 2023
View article titled, 203-LB: Prevalence and Risk Factors of Diabetic Peripheral Neuropathy—A Population-Based Cross-Sectional Study in China
Meeting Abstracts

393-P: SGLT2 Inhibitors Reduce Cardiovascular and Renal Risks Compared with GLP-1 Receptor Agonists and DPP4 Inhibitors in Patients with Diabetic Kidney Disease: A Systematic Review and Network Meta-analysis

HONGWEI CAO, TAO LIU, LI WANG, QIUHE JI
Journal: Diabetes
Diabetes 2022;71(Supplement_1):393-P
https://doi.org/10.2337/db22-393-P
Published: 01 June 2022
View article titled, 393-P: SGLT2 Inhibitors Reduce Cardiovascular and Renal Risks Compared with GLP-1 Receptor Agonists and DPP4 Inhibitors in Patients with Diabetic Kidney Disease: A Systematic Review and Network Meta-analysis
Meeting Abstracts

815-P: A Nationwide Cross-Sectional Survey of Knowledge and Practices of Diabetes Drug Injection Techniques of Patients, Nurses, and Physicians: The China IT Improve Study

LIXIN GUO, QIUHE JI, SHENG JIANG, DONGFANG LIU, JING LIU, XINGWU RAN, YAOMING XUE, QIU ZHANG
Journal: Diabetes
Diabetes 2022;71(Supplement_1):815-P
https://doi.org/10.2337/db22-815-P
Published: 01 June 2022
View article titled, 815-P: A Nationwide Cross-Sectional Survey of Knowledge and Practices of Diabetes Drug Injection Techniques of Patients, Nurses, and Physicians: The China IT Improve Study
Meeting Abstracts

17-OR: Efficacy and Safety of Chiglitazar, a Novel PPARα/γ/d Pan-Agonist, in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Superiority Trial (CMAP)

LINONG JI, WEIHONG SONG, HUI FANG, WEI LI, JIANLIN GENG, YAN CHENG XU, YANGANG WANG, LIAN GUO, HANQING CAI, TAO YANG, HONG-MEI LI, GANGYI YANG, QIFU LI, SR., KUANZHI LIU, SHUYING LI, YANJUN LIU, FUYAN SHI, XIN SHENG LI, XIN GAO, QIUHE JI, HAOMING TIAN, QING SU, ZHIGUANG ZHOU, WENBO WANG, ZUNHAI ZHOU, XUEJUN LI, YAN CHENG XU, ZHIQIANG NING, XIANPING LU, WEIPING JIA
Journal: Diabetes
Diabetes 2019;68(Supplement_1):17-OR
https://doi.org/10.2337/db19-17-OR
Published: 01 June 2019
View article titled, 17-OR: Efficacy and Safety of Chiglitazar, a Novel PPARα/γ/d Pan-Agonist, in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Superiority Trial (CMAP)
Meeting Abstracts

Efficacy and Safety of Sitagliptin (SITA)-Based Dual and Triple Combination Therapy in Older Chinese People with T2D

XIANGYANG LIU, LI WANG, YING XING, SAMUEL S. ENGEL, GUOJUAN CHEN, YE ZHANG, RUYA ZHANG, SHU LIU, JIANPING WENG, QIUHE JI
Journal: Diabetes
Diabetes 2018;67(Supplement_1):1144-P
https://doi.org/10.2337/db18-1144-P
Published: 01 July 2018
View article titled, Efficacy and Safety of Sitagliptin (SITA)-Based Dual and Triple Combination Therapy in Older Chinese People with T2D